Metraipolis › archive › dc_10bb85c70735

Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data — Europe PMC PMID:41980862

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41980862
DOI
10.1002/jcsm.70251
License (as archived)
solo-consultazione
Archived
2026-11-03T12:49:47.031Z
SHA-256 of the archived text
44363320e951cbf519d8f0f1402b5b1164aca9a3f0a6969525a9da47c2ed3de6
Stable URL of this page
https://metraipolis.com/documento/dc_10bb85c70735

How to cite

Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data — Europe PMC PMID:41980862 — Europe PMC (en), https://europepmc.org/article/MED/41980862 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_10bb85c70735 (Metraipolis archive dc_10bb85c70735, sha256 44363320e951cbf519d8f0f1402b5b1164aca9a3f0a6969525a9da47c2ed3de6)
BibTeX
@misc{dc10bb85c70735,
  title = {Muscle Atrophy-Related Adverse Events of Antidiabetic Drug Classes: A Pharmacovigilance Analysis Using VigiBase Data — Europe PMC PMID:41980862},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41980862},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_10bb85c70735; sha256 44363320e951cbf519d8f0f1402b5b1164aca9a3f0a6969525a9da47c2ed3de6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41980862. Agents can read the archived copy with the MCP tool read_document.